Phorm Corporation Limited AIM Rule 17 Disclosure Schedule Two (g) Update (9140X)
January 17 2014 - 1:00AM
UK Regulatory
TIDMPHRM
RNS Number : 9140X
Phorm Corporation Limited
17 January 2014
17 January 2014
Phorm Corporation Limited ("Phorm" or the "Company")
AIM Rule 17 Disclosure Schedule Two (g) Update
Phorm (AIM: PHRM), a leading internet personalisation technology
company, announces, in accordance with Rule 17 and Schedule Two (g)
sub-paragraph (v) of the AIM Rules for Companies, that it has been
notified of the following information by Lord Norman Lamont,
Non-Executive Director of Phorm:
Lord Lamont was, until 19 October 2012, a director of Balli
Group Plc ("Balli"), a private company incorporated in the UK.
Balli was placed into administration on 20 March 2013 and Deloitte
LLP were appointed as administrators.
In addition, Lord Lamont was, until 30 March 2009, a director of
Pantin Hotels (Management) Limited, a private company incorporated
in the UK, subsequently renamed Hallco 1063 Limited ("Hallco") on 7
May 2009. Hallco entered into a creditors' voluntary liquidation on
24 July 2009 with an estimated total deficit as regards creditors
on that date of GBP116,438. Hallco was dissolved on 14 January
2011.
-ends-
Contact
Phorm Corporation Limited
Andy Croxson (analysts & investors) +44 20 3397 6001
UK Investors
Mirabaud Securities LLP +44 20 7321 2508 (Joint Broker)
Jason Woollard
Peter Krens
Liberum Capital +44 20 3100 2222 (Nominated Advisor and Joint
Broker)
Chris Bowman
Richard Bootle
US Investors
Lippert Heilshorn and Associates +1 212 838 3777 (Investor
Relations)
John Heilshorn
About Phorm
Phorm is a global personalisation technology company that makes
content and advertising more relevant to the consumer. Phorm's
innovative platform preserves user privacy and delivers a more
interesting online experience.
Phorm's industry leading technology enables its ISP partners to
offer a new type of online advertising platform and a free consumer
internet content feature, ensuring more relevant advertisements and
personalised content for opted-in users.
Phorm's advertising platform revolutionises current standards of
online privacy, fully protecting the identity of consumers. Unlike
virtually all other targeted advertising propositions, Phorm's
solution is completely opt-in. Only those users consenting to the
service are profiled and only ever on an anonymous basis.
Phorm's partners include leading Internet Service Providers
(ISPs), Publishers, Advertising Networks and Advertisers.
Phorm, under a predecessor holding company, was admitted to the
AIM market of the London Stock Exchange in 2004.
For more information, please visit: www.phorm.com
This information is provided by RNS
The company news service from the London Stock Exchange
END
MSCSFFSIWFLSEEF
Phorm Corp (LSE:PHRM)
Historical Stock Chart
From Jun 2024 to Jul 2024
Phorm Corp (LSE:PHRM)
Historical Stock Chart
From Jul 2023 to Jul 2024